Introduction
Orthodontic tooth movement (TM) occurs during the bone remodeling sequence that is induced by therapeutic mechanical stress. 1 There occurs site-specific bone remodeling; bone resorption occurs on the compressed side, whereas bone formation occurs on the tensile side. Generally, 'ankylosed teeth,' in which the cementum of the tooth root is connected directly to the alveolar bone, cannot be moved by therapeutic mechanical stress because of a lack of periodontal ligament (PDL). 2 The mechanical stress loaded onto a tooth is transduced to the PDL; then, cells in the PDL respond to the mechanical stress to regulate the resorption and formation of the bone matrix by signaling the surrounding cells. 3 Osteoclasts form on the compressed side of an orthodontically moving tooth and resorb the alveolar bone. [4] [5] [6] Osteoclastogenesis is mainly regulated by two cytokines, receptor activator of nuclear factor kappa B ligand (RANKL) and macrophage colony-stimulating factor (M-CSF). 7 RANKL is a membrane-bound protein, expressed on the cell surface of the cells, which can support osteoclastogenesis, such as osteoblasts and stromal cells. 7 RANK, the receptor for RANKL, was identified and its expression was confirmed on the osteoclast lineage cells from precursors to mature osteoclasts. 8 RANKL signaling is inhibited by osteoprotegerin (OPG), 9 and a balance between RANKL and OPG contributes to the regulation of bone resorption. 10 Oshiro et al. 11 reported that RANKL induction was observed in the periodontal tissue of orthodontically moving tooth, and the RANK-RANKL regulation system was confirmed even in the site-specific bone remodeling that occurred during the orthodontic TM.
Numerous reports have described the pharmacological acceleration of TM through the activation of osteoclasts. Collins and Sinclair 12 reported that vitamin D 3 activated osteoclasts and rapid TM was observed. The local administration of prostaglandins, 13 osteocalcin, 14 or PTH 15 also induced orthodontic TM. However, because these drugs are rapidly flushed by blood circulation, daily systemic administration or daily local injection is needed.
Previously, we discovered that OPG gene transfer to the periodontal tissue induced prolonged-OPG expression, and inhibited RANKL-mediated osteoclastogenesis and experimental TM. 16 In this study, we hypothesized that local RANKL gene transfer to the periodontal tissue would boost RANKL concentration in the periodontal tissue, and thereby activate osteoclastogenesis and accelerate TM. To test our hypothesis, we employed experimental TM in rats either with or without local RANKL gene transfer via a hemagglutinating virus of Japan (HVJ) envelope vector gene delivery system ( Figure 1 ).
Results

In vitro assay
RANKL gene delivery and RANKL protein production in transfected cells were confirmed in vitro (Figures 2a  and b) . Furthermore, we performed a resorption assay to determine whether the produced RANKL was functionally intact (Figures 2c and d) . Rat bone marrow cells cultured with 1,25-(OH) 2 D 3 differentiated into osteoclasts, and there were many resorbed areas. However, when the medium collected from transfected cell cultures was added, osteoclastic resorption was obviously induced.
Animal status
At the start, the average weight of the rats was 14575.5 g. On day 21, average weights of rats in the control group, orthodontic force (OF) group, and mock group were 23278.3, 217712.7, and 22678.5 g, respectively. There was no significant difference between groups. OF and local gene transfer did not affect the growth of the animals. In addition, local gene transfer did not affect the bone mineral density (BMD) of the tibiae. The average BMDs of rats in the control group, OF group, and mock group were 1599756, 1623759, and 1591781 mg/mm 2 , respectively. There was no significant difference between groups. Furthermore, the local gene transfer caused no appreciable macroscopic changes at the local injection site. Next, we assessed how long RANKL gene transfer could induce RANKL protein expression in the periodontium. There was strong RANKL protein expression in the periodontium after 2 or 4 days from RANKL gene transfer (Figures 3d and e) . However, there were very few RANKL protein expressions in the periodontium after 6 days from RANKL gene transfer (Figure 3f ). The intensity of immunofluorescence on each day was measured (Figure 3g ). Compared to day À6, the intensity at days À2 and À4 were 72-fold and 55-fold, respectively. There is significant difference between days À2 and À4 (Po0.05). From these data, we performed RANKL gene transfer every three days during the experiment.
Then, we assessed the change of RANKL expression by OF or RANKL gene transfer. OF induced RANKL protein expression in the compressed periodontium (Figure 4b ). When the local RANKL gene transfer was performed in the control group, RANKL protein expression was induced locally in the periodontium, especially in the fibroblastic cells of PDLs and in the osteoblastic cells, which covered the alveolar bone surface ( Figure  4c ). The local RANKL gene transfer-induced RANKL protein production was observed not only in the compressed area of the periodontium but also in other areas of the periodontium. In addition, local RANKL 
Local RANKL gene transfer significantly increased the number of osteoclasts
First, we checked the effects of RANKL gene transfer to the number of osteoclasts in the periodontium ( Figure 5 ). The number of osteoclasts was high at day À2 after RANKL gene transfer (6.171.5 cells). The number of osteoclasts was reduced time dependently (day À4: 4.171.0 cells, day À6: 0.970.3 cells, respectively). This reduction was similar to the time-dependent RANKL attenuation ( Figure 3 ). OF induced osteoclastogenesis in the palatal side of the compressed periodontium (Figure 6a ). In addition, local RANKL gene transfer also induced osteoclastogenesis in the periodontium (Figure 6b ). This osteoclastogenesis induction was observed not only in the compressed periodontium but also other areas of the periodontium (Figure 6d) . Interestingly, local RANKL gene transfer also induced osteoclastogenesis even without OF application (Figure 7 ).
Local RANKL gene transfer significantly accelerated TM
After three days, the TM in the RANKL transfection side was significantly increased over that in the contralateral side (Po0.005) (Figure 8) 
Discussion
Experimental procedures
In this study, we employed an experimental TM system, using a fixed orthodontic appliance (Figure 1 ) that constantly generated a light effective OF to M1 of the maxilla. 17 The OF application to the rats did not affect body weights or BMD of tibia. These results suggest that the magnitude of the applied OF in this study was appropriate for the experimental rats. Local RANKL gene transfer using HVJ envelope vector gene delivery system can perform local gene transfer to the periodontal tissue without systemic effects. This HVJ envelop vector is a nonviral gene transfer system, and there are many advantages compared to the commonly used gene transfer system. First, the immunogenicity of HVJ envelope vector is very low compared to the highly immunogenic vectors such as adenoviral vector, and it is beneficial for long-term gene expression and safety. 18 Second, Tsuboniwa et al. 19 reported that the HVJ liposome method is safe and repeated administration can be performed without causing undesirable side effects, such as inflammation. In this experiment, we performed administration every third day because of short attenuation time of our local gene transfer system. From our preliminary experiment, our local gene transfer system enabled protein induction until 5 days after transfer. However, compare to day 3, the induction of the protein expression was relatively weak at day 5. Our aim of this study is to clarify, 'RANKL gene transfer could accelerate orthodontic TM', so we decided to administrate every third day.
HVJ envelope vector containing pcDNA-mRANKL enabled local RANKL expression in the periodontium and induced osteoclastogenesis From the in vitro assay, RANKL expression plasmid can produce functional soluble RANKL protein (Figure 2 ). RANKL protein production was observed in the PDL fibroblast-like cells and osteoblastic cells, which covered the alveolar bone (Figures 3 and 4) . There may be a difference in the transfection efficiency or RANKL protein production ability between the cell types. Many researchers reported the expression of RANKL in periodontal tissue during experimental TM. Ogasawara 20 examined RANKL mRNA expression in PDL and reported that RANKL-positive cells showed no specic distribution pattern. Sasaki and Oshiro et al. 21, 22 examined RANKL protein expression in PDL and reported that RANKL immunostaining was clearly observed in osteoblasts facing the alveolar bone surfaces, PDL fibroblasts, and multinucleated osteoclasts. Compared to their results, the local RANKL gene transfer-induced RANKL protein production was observed not only in the compressed area of the periodontium, but also in other areas of the periodontium.
RANKL gene transfer induces TM
In this experiment, we had not confirmed OPG expression in the periodontal tissue. Fukushima et al. 23 reported that PDL cells express RANKL and decrease OPG expression, and regulate physiological root resorption during the root-resorbing stage of the deciduous tooth. In addition, Hasegawa et al. 24 reported that PDL cells synthesize both RANKL and OPG and that inactivation of OPG may play a key role in the differentiation of osteoclasts. However, we reported that PDL cells under compression showed RANKL upregulation and constant-OPG expression. 25 RANKL-OPG ratio may become RANKL dominant in the periodontium under compressive force.
Previously, we had performed local OPG gene transfer to the periodontal tissue, and induction of OPG expres- 
H Kanzaki et al sion was observed not only in the transferred palatal side, but also in the buccal side. 16 Therefore, local RANKL gene transfer could induce RANKL protein production not only in the palatal side of M1 but also all around M1. Local RANKL gene transfer significantly induced the osteoclastogenesis not only in the compressed area of the periodontium, but also in other areas of the periodontium (Figures 6a-d ). This may occur by diffused RANKL protein production in the periodontium. In addition, we used RANKL gene coding for only the extracellular domain, so the product is in its soluble form. Soluble RANKL production from transfected cells would support osteoclastogenesis from osteoclast precursors circulating through the bloodstream.
The relationship between RANKL expression and the number of osteoclasts was confirmed (Figures 3 and 5) . The number of osteoclasts reduced with the attenuation of RANKL expression in the periodontium. Udagawa et al. 7 reported that RANKL in not only an osteoclast differentiation factor but also an osteoclast survival factor. There is no difference in the number of osteoclasts between control of NO-OF and control of OF (Figure 7) . We postulate that the reasons for this equality are as follows. There is physiological distal movement in rats. So there area number of osteoclasts at the distal side of the alveolar bone. However, osteoclasts induced by orthodontic loading in this experiment are emerge at the palatal side of alveolar bone. We measured the number of osteoclasts all around the tooth, so there is no difference in the number of osteoclasts.
Local RANKL gene transfer induced accelerated TM
Compared to the normal TM samples, the TM rate of the local RANKL gene transfer samples was approximately 30-70 percent more, and this induction decreased over the experimental period (Figure 8) . From this result, we can gather that only the early stage of TM might be dependent on RANKL-mediated osteoclastogenesis. However, the relationship between the number of osteoclasts and RANKL expression was confirmed (Figures 3 and 5 ). There is another reason for this reduction of TM. Interestingly, the local RANKL gene transfer without OF showed slight TM (Figure 8 ). Appropriate RANKL production might be required for orthodontic TM.
Numerous reports have described the pharmacological acceleration of TM through the activation of osteoclasts. Collins and Sinclair 12 reported that vitaminD 3 activated osteoclasts, and rapid TM was observed. The local administration of prostaglandins, 13 osteocalcin, 14 or PTH 15 also induced orthodontic TM. However, because these drugs are rapidly absorbed into blood, daily systemic administration or daily local injection is needed. Local gene transfer has two advantages. 26 First, it can maintain a local effective concentration and prolonged protein expression, regardless of blood circulation. Second, protein expression occurs at a local site, avoiding systemic effects.
RANK-RANKL signaling has been studied as a candidate of gene therapy for diseases of bone metabolism, such as osteoporosis, arthritis, and bone graft, because of the confined role in cell signaling. Bolon et al. 27 reported that OPG gene transfer could inhibit bone resorption in a mouse ovariectomy model of osteoporosis. Goater et al. 28 reported that ex vivo OPG gene therapy could prevent osteolysis. Ito et al. 29 reported that virusmediated RANKL gene transfer could induce grafted bone remodeling.
In this study, we demonstrated that RANKL gene transfer to the periodontal tissue-induced osteoclastogenesis and accelerated experimental TM, without eliciting any systemic effects. Osteoclastogenesis in response to orthodontic TM appears to be regulated primarily through RANKL signaling in periodontal cells. Local RANKL gene transfer might be a useful tool not only for shortening orthodontic treatment, but also for moving ankylosed teeth where teeth fuse to the surrounding bone.
Materials and methods
Animals and orthodontic appliance
All animals were treated ethically, in compliance with the regulations of Tohoku University. In total, 25 6-week-old male Wistar rats were used in this study. They were divided into three groups. Of these rats, 10 were used as controls (control group), and 11 rats were subjected to an applied OF group. Local RANKL gene transfer was performed on the right side of the maxilla of the OF group as described below (Figure 1a ). In addition, for the purpose of testing transfection, we transfected four rats with mock vector (mock group). The standardized compressive spring (Figure 1a ) was used for moving the teeth. 16 Cloning of the mouse RANKL gene and construction of the RANKL expression plasmid Total RNA was extracted from the mouse osteoblastic cell-line MC3T3-E1 and then reverse transcribed. Firststrand cDNA was subjected to PCR amplification using specific PCR primers, designed using mouse RANKL cDNA plus restriction site, primer XhoI site+RANKL-upstream (5 0 -GGGCTCGAGATGCCTGAGGCCCAGCC ATTTGC-3 0 ) and primer RANKL-downstream+XbaI site (5 0 -CTAGTCTAGAACAGCCCAGTGACCATTC-3 0 ). The amplified cloning plasmid vector containing the restric- 
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tion site-tagged RANKL sequence was digested with both XhoI and XbaI restriction enzymes, and the insert was ligated into the linearized expression plasmid vector pcDNA3.1(+). The sequence was confirmed using ALFexpresstCyt5Thermo-SequenasetDye Terminator kit (Amersham Biosciences, Piscataway, NJ, USA). This RANKL expression vector (pcDNA-mRANKL) was driven by a cytomegalovirus (CMV) promoter; the sequence encoded the functional mouse soluble RANKL (AF019048, 606-1086 bp). The sequence was modified from 607-609 bp to the methionine. Amplified pcDNAmRANKL was purified with Triton X-114 to remove bacterial endotoxin.
In vitro assay of the constructed RANKL expression plasmid
The constructed RANKL expression plasmid was transfected into NIH3T3cells. At 72 h after transfection, culture media and whole protein were collected. From the whole protein, RANKL production was analyzed by Western blotting. The functional activity of the RANKL in the culture media was tested with a bone-resorption assay using calcium phosphate-coated discs (Osteologic s , BD Biosciences, Ontario, Canada).
In vivo gene transfer
For in vivo transfection, we used an HVJ envelope vector kit. The administration of HVJ envelope vector containing pcDNA-mRANKL to the experimental animals was started on the initial day of OF application. Under anesthesia, vector solution (5 ml) was injected into the subperiosteal area, adjacent to the maxillary right M1 on days 0, 3, 7, 10, 14, and 17 of the experiment (Figure 1a) . On the contralateral side, PBS(5 ml) were injected into the corresponding area. In the mock group, 5 ml of mock vector solution was injected into the corresponding area.
Measurement of TM
The movement of M1 was measured as described previously (Figure 1) . 16 The error in measurement was 0.011 mm, when a single investigator measured 20 randomly selected samples in blind tests.
Measurement of BMD of tibiae
After killing the experimental animals, BMD of tibiae were measured as described previously. 16 The densitometric patterns of the proximal tibiae, especially the cancellous-bone area, were measured using ScionImage s .
Cytochemical and histological examinations
Animals were killed under pentobarbital anesthesia on day 21, and the tissues were fixed by perfusion with 4% paraformaldehyde in PBS. Specimens were then decalcified, dehydrated, and embedded in paraffin. Periodontal tissues of the mesiopalatal root of M1 were examined in serial cross-sections at a bifurcation level. TRAP-positive multinucleated cells that formed resorption lacunae on the alveolar bone surface adjacent to the mesiopalatal root of M1 were counted.
Immunohistochemical analysis for RANKL
In brief, the sections were deparaffinized, preincubated in 5% bovine serum albumin, and subsequently incubated with anti-RANKL antibody. After being thoroughly rinsed, the sections were incubated with the FITC-conjugated anti-goat IgG, washed, mounted in PBS-glycerol, and observed with a fluorescence microscope.
Statistics
Data were analyzed for statistical differences using the Kruskal-Wallis analysis, followed by a Bonferroni-type multiple comparison (Tukey type). Differences with Po0.05 were considered significant. The values are expressed as mean7s.d.
